Ilicol is widely used in the pharmaceutical industry as an intermediate in the synthesis of anti-inflammatory and analgesic agents. It exhibits inhibitory activity against certain enzymes involved in inflammatory pathways, making it valuable in the development of drugs targeting chronic inflammation and pain. Due to its structural properties, it is also employed in research settings for designing novel bioactive molecules. Additionally, Ilicol has found applications in dermatological formulations where modulation of skin cell activity is required, particularly in treatments for acne and psoriasis. Its compatibility with various delivery systems enhances its utility in topical and oral dosage forms.